Portfolio of Medical Diagnostic Stocks

Here are 13 companies that offer medical diagnostic products.

13 Medical Diagnostic Stocks

Stock Returns & Price Chart


Recent Prices &
Annualized Return

Accelerate DiagnosticsAXDX
Exact SciencesEXAS
IDEXX LaboratoriesIDXX
Meridian BioscienceVIVO
Myriad GeneticsMYGN
Navidea BiopharmaceuticalsNAVB
Oxford Immunotec Global PLCOXFD
Trinity Biotech plcTRIB
Price data from Quandl as of most recent close.

To inspect the performance of the Medical Diagnostic Stocks portfolio, see the chart below. Portfolio values are computed using monthly closes for stocks from Quandl.

The 12 stocks included in the portfolio computations are: AXDX, EXAS, IDXX, VIVO, MYGN, NAVB, NEOG, OPK, QGEN, QDEL, SRDX and TRIB. The current value of the portfolio assumes that $833.33 was invested (total of $10,000) in each stock at its closing monthly price for the first date shown on the portfolio value chart below. All prices are adjusted for splits and dividends. OXFD was excluded from the portfolio computations because of insufficient price data.

The current value of a $10,000 investment is $66,370. The percent return is 563.70%. The annualized return is 20.84%.

Return Summary for Medical Diagnostic Stocks
Start DateSep-30-2009
Start Investment$10,000.00
End DateSep-19-2019
Current Value of Investment$66,369.95
Total Return563.70%
Annualized Return20.84%
Min DateNov-30-2009
Min Price$8,910.24
Max DateJun-28-2019
Max Price$70,811.94
# Values121
Number Returns7,260
Number Profitable Returns6,680
Percent Profitable Returns92.01%
Number Unprofitable Returns580
Percent Unprofitable Returns7.99%
Profitable to Unprofitable Returns Ratio11.52

NOTE: The stocks included in the tables and chart are representative of the industry. They are not recommendations.

Related Portfolio

Portfolio of Medical Device Maker Stocks

Portfolio of Medical Equipment Stocks

Portfolio of Medical Instruments and Supplies Stocks

Portfolio of Medical Laboratory and Research Stocks